Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Bäuerle, Tobias [VerfasserIn]   i
 Bartling, Sönke [VerfasserIn]   i
 Berger, Martin R. [VerfasserIn]   i
 Schmitt-Gräff, Annette [VerfasserIn]   i
 Hilbig, Heidegard [VerfasserIn]   i
 Kauczor, Hans-Ulrich [VerfasserIn]   i
 Delorme, Stefan [VerfasserIn]   i
 Kiessling, Fabian [VerfasserIn]   i
Titel:Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
Verf.angabe:Tobias Bäuerle, Sönke Bartling, Martin Berger, Annette Schmitt-Gräff, Heidegard Hilbig, Hans-Ulrich Kauczor, Stefan Delorme, Fabian Kiessling
Jahr:2010
Umfang:8 S.
Fussnoten:Online verfügbar 12 Dezember 2008 ; Gesehen am 29.11.2022
Titel Quelle:Enthalten in: European journal of radiology
Ort Quelle:Amsterdam [u.a.] : Elsevier Science, 1990
Jahr Quelle:2010
Band/Heft Quelle:73(2010), 2, Seite 280-287
ISSN Quelle:1872-7727
Abstract:As current classification systems for the assessment of treatment response in bone metastasis do not meet the needs of oncologists, new imaging biomarkers are desirable. Therefore, the diagnostic impact of dynamic contrast enhanced (DCE)-volumetric computed tomography (VCT) (descriptive analysis), DCE-MRI (two-compartment model) and diffusion weighted imaging (DWI) for monitoring anti-angiogenic therapy effects of the VEGF antibody bevacizumab in breast cancer bone metastases in rats was studied. Nude rats (n=8 animals treated with bevacizumab and n=9 untreated control rats) with site-specific osteolytic bone metastasis of the hind leg were imaged with a 1.5T clinical MRI-scanner in an animal coil as well as in a volumetric CT-scanner at days 30, 40, 50 and 60 after inoculation of MDA-MB-231 human breast cancer cells. From these data, osteolytic lesion size (OLS), peak enhancement (PE), area under the curve (AUC), amplitude (A), exchange rate constant (kep) and apparent diffusion coefficient (ADC) were determined in bone metastases. Prior to changes in OLS (p≤0.05 at days 50 and 60) there was already a significant decrease in PE, AUC and A (p≤0.05 at days 40-60) in treated animals compared to controls. However, for kep and ADC there were no significant differences between the groups at any time point (p>0.05 at days 40-60). In conclusion, anti-angiogenic treatment response in osteolytic breast cancer bone metastases can be assessed early with surrogate markers of vascularization, while DWI appears to be insensitive.
DOI:doi:10.1016/j.ejrad.2008.10.020
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1016/j.ejrad.2008.10.020
 Volltext: https://www.sciencedirect.com/science/article/pii/S0720048X08005780
 DOI: https://doi.org/10.1016/j.ejrad.2008.10.020
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Angiogenesis
 Bone metastasis
 Diffusion weighted imaging
 Dynamic contrast enhanced MRI
 Dynamic contrast enhanced volumetric CT
K10plus-PPN:1823871070
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68990482   QR-Code
zum Seitenanfang